Ipsen Inc Drug Patent Portfolio
Ipsen Inc owns 1 orange book drug protected by 3 US patents Given below is the list of Ipsen Inc's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US5681814 | Formulated IGF-I Composition | 18 Sep, 2017 | Expired |
| US5824642 | Treatment of partial growth hormone insensitivity syndrome | 08 Jul, 2014 | Expired |
| US6207640 | Treatment of partial growth hormone insensitivity syndrome | 07 Apr, 2014 | Expired |
Ipsen Inc's Family Patents
Ipsen Inc Drug List
Given below is the complete list of Ipsen Inc's drugs and the patents protecting them.
1. Increlex
Increlex is protected by 3 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US5681814 | Formulated IGF-I Composition |
18 Sep, 2017
(7 years ago)
| Expired |
| US5824642 | Treatment of partial growth hormone insensitivity syndrome |
08 Jul, 2014
(10 years ago)
| Expired |
| US6207640 | Treatment of partial growth hormone insensitivity syndrome |
07 Apr, 2014
(10 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Increlex's drug page
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List